PDB Short entry for 2LU0 HEADER RNA 05-JUN-12 2LU0 TITLE NMR SOLUTION STRUCTURE OF THE KAPPA-ZETA REGION OF S.CEREVISIAE GROUP TITLE 2 II INTRON AI5(GAMMA) COMPND MOL_ID: 1; COMPND 2 MOLECULE: RNA (49-MER); COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: SACCHAROMYCES CEREVISIAE; SOURCE 4 ORGANISM_TAXID: 4932; SOURCE 5 OTHER_DETAILS: SEQUENCE OCCURS NATURALLY IN S.CEREVISIAE AND WAS SOURCE 6 SYNTHESIZED IN VITRO USING T7 POLYMERASE AND SYNTHETIC DNA SOURCE 7 OLIGONUCLEOTIDES KEYWDS RNA, THREE-WAY JUNCTION, METAL ION, GROUP II INTRON, RIBOZYME EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR D.DONGHI,M.PECHLANER,C.FINAZZO,B.KNOBLOCH,R.K.O.SIGEL REVDAT 2 14-JUN-23 2LU0 1 REMARK REVDAT 1 10-APR-13 2LU0 0 JRNL AUTH D.DONGHI,M.PECHLANER,C.FINAZZO,B.KNOBLOCH,R.K.O.SIGEL JRNL TITL THE STRUCTURAL STABILIZATION OF THE KAPPA THREE-WAY JUNCTION JRNL TITL 2 BY MG(II) REPRESENTS THE FIRST STEP IN THE FOLDING OF A JRNL TITL 3 GROUP II INTRON. JRNL REF NUCLEIC ACIDS RES. V. 41 2489 2013 JRNL REFN ISSN 0305-1048 JRNL PMID 23275550 JRNL DOI 10.1093/NAR/GKS1179 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2, X-PLOR NIH 2.30 REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 (CNS), SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE (X- REMARK 3 PLOR NIH) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2LU0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-JUN-12. REMARK 100 THE DEPOSITION ID IS D_1000102831. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 300; 275-285 REMARK 210 PH : 6.5-6.9; 6.5-6.9 REMARK 210 IONIC STRENGTH : 60; 60 REMARK 210 PRESSURE : AMBIENT; AMBIENT REMARK 210 SAMPLE CONTENTS : 0.3-1.0 MM RNA (49-MER), 60 MM REMARK 210 POTASSIUM CHLORIDE, 10 UM EDTA, REMARK 210 0-12 MM MAGNESIUM CHLORIDE, 100% REMARK 210 D2O; 0.3-1.0 MM [3',4',5',5 ,5- REMARK 210 D5] RNA (49-MER), 60 MM REMARK 210 POTASSIUM CHLORIDE, 10 UM EDTA, REMARK 210 0-12 MM MAGNESIUM CHLORIDE, 100% REMARK 210 D2O; 0.3-1 MM 100% 13C; 100% 15N REMARK 210 RNA (49-MER), 60 MM POTASSIUM REMARK 210 CHLORIDE, 10 UM EDTA, 0-12 MM REMARK 210 MAGNESIUM CHLORIDE, 100% D2O; REMARK 210 0.3-1.0 MM RNA (49-MER), 60 MM REMARK 210 POTASSIUM CHLORIDE, 10 UM EDTA, REMARK 210 0-12 MM MAGNESIUM CHLORIDE, 90% REMARK 210 H2O/10% D2O; 0.3-1.0 MM 100% 13C; REMARK 210 100% 15N RNA (49-MER), 60 MM REMARK 210 POTASSIUM CHLORIDE, 10 UM EDTA, REMARK 210 0-12 MM MAGNESIUM CHLORIDE, 90% REMARK 210 H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H TOCSY; 2D 1H-1H NOESY; REMARK 210 2D 1H-15N HSQC; 2D 1H-13C HSQC; REMARK 210 3D 1H-13C NOESY ALIPHATIC; 2D REMARK 210 JNN HNN COSY REMARK 210 SPECTROMETER FIELD STRENGTH : 700 MHZ; 600 MHZ; 900 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CNS 1.2, SPARKY, X-PLOR NIH REMARK 210 2.30, MOLMOL, TOPSPIN REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS, REMARK 210 SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O2' A A 6 H6 U A 7 1.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 18503 RELATED DB: BMRB DBREF 2LU0 A 1 49 PDB 2LU0 2LU0 1 49 SEQRES 1 A 49 G G A A U A U G C U C A A SEQRES 2 A 49 C G A A A G U G A A U C A SEQRES 3 A 49 G C U U C G G C U G A G A SEQRES 4 A 49 G C U A A G U U C C CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000